Article and Video CATEGORIES

Cancer Journey

Search By

Nancy has a background in molecular biology and over 25 years of experience in medical education and healthcare communications. Much of her professional experience has focused in the area of oncology and has included oversight of grant-funded educational programming, advisory board planning and execution, scientific communications and publication planning, clinical support and clinical trial awareness initiatives, as well as educational content development and dissemination.

Congratulations on 10 Fantastic Years - Meet Nancy Sladicka, Member of the Board
GRACE celebrates 10 years as a non profit! Meet the dedicated staff and board who work so hard to bring this amazing site to life.
Author
Nancy Sladicka, PhD
Image

GRACE is celebrating 10 years! 


In recognition, we would like to introduce you to the staff and board members who are so deeply involved in bringing GRACE to life. In this video, we introduce Nancy Sladicka.

Dr. H. Jack West and the GRACE community have been helping each other since before that time but in this 10th year as a non-profit, we are pleased and humbled by the feedback and graciousness of those we have the pleasure to work with, and those who have found help and support through our GRACE site.


We are more than pleased to be able to continue our mission to provide expert-mediated information on current and emerging cancer management options in order to empower patients, caregivers, and health professionals to become direct partners in cancer care. http://cancerGRACE.org/

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Blood Cancers OncTalk
Article
Registration is now open! Join us for the annual 2024 Blood Cancers OncTalk!  Register Now!
Image
PEA 2024-25 final
Article
GRACE is pleased to announce the acceptance of five rising stars into the 6th year of the GRACE Patient Education Ambassadors Program for the 2024-25 Program Year! 
Image
2024 patient education ambassadors program
Article
Applications are now open to oncology fellows and finishing fellows Program Information Form and Application

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on